本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.10
-0.1000-8.33%
盘后1.100.00000.00%16:31 EDT
成交量:50.40万
成交额:59.15万
市值:6,814.24万
市盈率:-0.70
高:1.24
开:1.22
低:1.10
收:1.20
数据加载中...
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/28

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/29

SEC问询函

Form CORRESP - Correspondence
2023/08/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/23

重要事件披露

Form 8-K - Current report
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities